Results 101 to 110 of about 28,866 (196)

Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)

open access: yesBMC Pharmacology and Toxicology, 2019
Background Neurofibromatosis 1 and 2, although involving two different tumour suppressor genes (neurofibromin and merlin, respectively), are both cancer predisposition syndromes that disproportionately affect cells of neural crest origin. New therapeutic
Yu-chi Shen   +8 more
doaj   +1 more source

Blue‐Gray Papules on the Chest and Face

open access: yes
JEADV Clinical Practice, Volume 5, Issue 1, Page 326-329, March 2026.
Sanjana Likki   +5 more
wiley   +1 more source

Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions

open access: yesOncology and Therapy
Neurofibromatosis type 2 (NF2)-related schwannomatosis is a rare autosomal dominant monogenic disorder caused by mutations in the NF2 gene. The hallmarks of NF2-related schwannomatosis are bilateral vestibular schwannomas (VS).
Ruofei Yuan   +3 more
doaj   +1 more source

Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis

open access: yesNeurologia Medico-Chirurgica
Meningioma is the second most frequent tumor in patients with neurofibromatosis type 2 (NF2). The presence of meningioma is believed to be a negative prognostic marker in these patients.
Takeshi IMURA   +2 more
doaj   +1 more source

Retinal Ischemia as a Presenting Ocular Sign of Neurofibromatosis Type 2

open access: yesCase Reports in Ophthalmological Medicine
Purpose. Specific retinal abnormalities of neurofibromatosis type 2 (NF2) commonly include retinal astrocytoma and combined hamartoma of the retina and retinal pigment epithelium. Vasculopathy is an uncommon manifestation of NF2.
Binbin Zhao, Yan Yan
doaj   +1 more source

Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature

open access: yesBMC Medical Genetics, 2012
Background Pierre-Robin sequence (PRS) is defined by micro- and/or retrognathia, glossoptosis and cleft soft palate, either caused by deformational defect or part of a malformation syndrome.
Davidson Tom B   +7 more
doaj   +1 more source

Schwannomatosis of the Spinal Accessory Nerve: A Case Report. [PDF]

open access: yes, 2019
Schwannomatosis is a distinct syndrome characterized by multiple peripheral nerve schwannomas that can be sporadic or familial in nature. Cases affecting the lower cranial nerves are infrequent.
Chin, Cynthia T   +4 more
core  

Additional file 2 of Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic

open access: yes, 2020
Additional file 2: Figure S1 shows the genome-wide copy-number alteration data of eligible cases. Loss of chromosome 22q (84.1%) and loss of chromosome 1p (68.8%) were the most common copy number alterations.
Williams, Erik A.   +13 more
openaire   +1 more source

The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis

open access: yesScientific Reports
NF2-related schwannomatosis (NF2-SWN) is a rare genetic disorder and is associated with progressive morbidities. This study aimed to investigate the relationship between NF2-SWN disease severity, health-related Quality of Life (QoL), and mental health ...
Anna Freier   +4 more
doaj   +1 more source

NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

open access: yesnpj Precision Oncology
Neurofibromatosis type 2 (NF2) is a tumor suppressor gene implicated in various tumors, including mesothelioma, schwannomas, and meningioma. As a member of the ezrin, radixin, and moesin (ERM) family of proteins, merlin, which is encoded by NF2 ...
Duo Xu, Shiyuan Yin, Yongqian Shu
doaj   +1 more source

Home - About - Disclaimer - Privacy